Cimeio Therapeutics AG
Industry
- Biotechnology
- Gene Therapy, Cell Therapy
- Pharmaceuticals
See more in Biomedtracker
Latest on Cimeio Therapeutics AG
Scrip
• By Joseph Haas, Lisa Takagi, Ian Haydock, and Vibha Ravi
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Kaken Obtains Aadi’s Fyarro, Comm
Scrip
• By Joseph Haas, Ian Haydock, and Lisa Takagi
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Talaris Calls It Quits In Reverse-Merge
Scrip
• By Mandy Jackson and Kevin Grogan
The series C venture capital round that Tessera Therapeutics announced on 19 April – totaling more than $300m, the company said – shows that investors continue to be willing to invest large sums in